By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Solace Therapeutics, Inc. 

139 Newbury Street

Framingham  Massachusetts  01701  U.S.A.
Phone: 508-283-1200 Fax: n/a


Medical Device

Company News
Solace Therapeutics, Inc. Completes Enrollment Of The SUCCESS Clinical Trial For The Vesair Bladder Control System For Stress Urinary Incontinence 8/26/2015 10:51:20 AM
Solace Therapeutics, Inc. Release: Presentations At The International Urogynecology Association (IUGA) Conference In Nice, France Continue To Demonstrate Safety And Efficacy Of The VesairĀ® Bladder Control Procedure As A Treatment For Stress Urinary Incontinence(SUI) 6/8/2015 10:51:25 AM
Solace Therapeutics, Inc. Release: A Second Randomized Controlled Trial (RCT) Of The Vesair Bladder Control System Meets Study Endpoints With Statistical Significance 2/17/2015 2:20:53 PM
Solace Therapeutics, Inc. Wins Two FDA Clearances Towards Providing Women An Office-Based Treatment For Stress Urinary Incontinence (SUI). 6/18/2014 10:25:16 AM
Solace Therapeutics, Inc. Adds New Member to Board of Directors 9/17/2013 8:37:19 AM
Solace Therapeutics, Inc. Comforted by $7 Million 3/29/2012 8:58:18 AM
Solace Therapeutics, Inc. Announces CE Mark Approval 10/1/2009 10:41:33 AM